What could delay the vaccine rollout?
One of the concerns is export restrictions in Europe. Facing severe vaccine shortfalls, the European Union last week announced export controls on coronavirus vaccines, requiring drugmakers to gain export authorization, thereby prioritizing shipments to EU countries. AstraZeneca, which has signed a contract to supply 120 million doses to Japan, was set to export 30 million shots to Japan by the end of March, but Taro Kono, the minister in charge of the vaccination drive, has expressed concerns about delivery delays. The firm is considering manufacturing the remaining doses in Japan.
The government has been making final arrangements for the first batch of Pfizer vaccines to arrive in Japan from Belgium as early as Feb. 14, local reports have said, but the government has not made such information public due to concerns about unexpected circumstances such as acts of terrorism.
Securing storage for the vaccines, which need to be kept at a low temperature, could also be a problem.
The government has secured 20,000 freezers to store vaccines, and the distribution of deep freezers to store Pfizer’s vaccine, which need to be kept at minus 75 degrees Celsius, to municipalities began this week. The government plans to distribute 3,370 deep freezers for Pfizer vaccines by the end of March, but no plans for deploying freezers for Moderna vaccines have been set as of now.